The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

The CYP2C192 and CYP2C1917 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

Item

http://www.wikidata.org/entity/Q54627886

Q54627886

about

The CYP2C192 and CYP2C1917 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

Item

http://www.wikidata.org/entity/Q54627886

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The CYP2C19*2 and CYP2C19*17 P ...... ion: A Pharmacogenomics Study.

@en

The CYP2C19*2 and CYP2C19*17 P ...... ion: A Pharmacogenomics Study.

@nl

type

Item

label

The CYP2C19*2 and CYP2C19*17 P ...... ion: A Pharmacogenomics Study.

@en

The CYP2C19*2 and CYP2C19*17 P ...... ion: A Pharmacogenomics Study.

@nl

prefLabel

The CYP2C19*2 and CYP2C19*17 P ...... ion: A Pharmacogenomics Study.

@en

The CYP2C19*2 and CYP2C19*17 P ...... ion: A Pharmacogenomics Study.

@nl

P1476

The CYP2C19*2 and CYP2C19*17 P ...... tion: A Pharmacogenomics Study

@en

P2093

Alparslan Birdane

http://www.w3.org/2001/XMLSchema#string

Ertuğrul Çolak

http://www.w3.org/2001/XMLSchema#string

Faruk Saydam

http://www.w3.org/2001/XMLSchema#string

Hasan Veysi Güneş

http://www.w3.org/2001/XMLSchema#string

Mahmut Özdemir

http://www.w3.org/2001/XMLSchema#string

Necmi Ata

http://www.w3.org/2001/XMLSchema#string

Taner Ulus

http://www.w3.org/2001/XMLSchema#string

İrfan Değirmenci

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Response variability to P2Y12 receptor inhibitors: expectations and reality

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation

Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

Clopidogrel "resistance": where are we now?

Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population

P304

29-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCPT.12763

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Cansu Ozbayer

P577

2017-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28135763

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

about

The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

The CYP2C192 and CYP2C1917 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.

The CYP2C192 and CYP2C1917 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.